scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1037710076 |
P356 | DOI | 10.1186/1471-2458-9-284 |
P932 | PMC publication ID | 2731750 |
P698 | PubMed publication ID | 19656386 |
P5875 | ResearchGate publication ID | 26718574 |
P50 | author | Maria Rubio-Valera | Q43088190 |
Antoni Serrano-Blanco | Q43088197 | ||
Marian A. March | Q71977022 | ||
M T Peñarrubia María | Q73857122 | ||
P2093 | author name string | Marian March Pujol | |
Pere Travé | |||
Mar Ruiz | |||
P2860 | cites work | Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 |
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project | Q22242341 | ||
Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys | Q22252996 | ||
The PHQ-9: validity of a brief depression severity measure | Q24550620 | ||
EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
The revised CONSORT statement for reporting randomized trials: explanation and elaboration | Q29618913 | ||
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire | Q33777234 | ||
Treatment non-adherence in affective disorders. | Q34592227 | ||
Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management | Q36915765 | ||
Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management | Q36966475 | ||
Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain project | Q37129559 | ||
Concurrent and predictive validity of a self-reported measure of medication adherence | Q39512844 | ||
Cost of depression in Europe | Q40284204 | ||
Development and validation of a Spanish language patient satisfaction questionnaire with drug dispensing | Q42632237 | ||
Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients | Q43648407 | ||
Prevalence of mental disorders in primary care: results from the diagnosis and treatment of mental disorders in primary care study (DASMAP). | Q44390153 | ||
Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. | Q46493733 | ||
Patient outcomes following an intervention involving community pharmacists in the management of depression. | Q51775849 | ||
Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study. | Q51895170 | ||
Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. | Q51940991 | ||
Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. | Q51942571 | ||
Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. | Q53576646 | ||
Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants | Q57829480 | ||
The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients | Q58723304 | ||
A Pharmacy-Based Coaching Program to Improve Adherence to Antidepressant Treatment Among Primary Care Patients | Q60472725 | ||
The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients | Q69903875 | ||
[The Spanish version of EuroQol: a description and its applications. European Quality of Life scale] | Q73319178 | ||
[One year prevalence of mental disorders comorbidity and associated socio-demographic risk factors in the general population of Spain. Results of the ESEMeD-Spain study] | Q80672918 | ||
[The impact of mood and anxiety disorders, and physical chronic conditions in the quality of life of general population of Spain. Results of the ESEMeD-Spain study] | Q80672923 | ||
Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies | Q82787843 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 284 | |
P577 | publication date | 2009-08-05 | |
P1433 | published in | BMC Public Health | Q15767009 |
P1476 | title | Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol | |
P478 | volume | 9 |
Q34947318 | Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study). |
Q34329474 | Factors affecting collaboration between general practitioners and community pharmacists: a qualitative study. |
Q34162026 | Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review |
Q57688816 | Pharmacist services for non-hospitalised patients |
Q42011793 | Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement |
Q58114372 | Role and impact of pharmacists in Spain: a scoping review |
Q50436405 | [Impact of pharmaceutical intervention in preventing relapses in depression in Primary Care]. |
Search more.